Cargando…

Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease

[Image: see text] Nowadays, nutraceuticals are being incorporated into functional foods or used as supplements with nonpharmacological approaches in the prevention and management of several illnesses, including age-related conditions and chronic neurodegenerative diseases. Nutraceuticals are apt for...

Descripción completa

Detalles Bibliográficos
Autores principales: Reza-Zaldívar, Edwin E., Jacobo-Velázquez, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552500/
https://www.ncbi.nlm.nih.gov/pubmed/37810693
http://dx.doi.org/10.1021/acsomega.3c04855
_version_ 1785115976569716736
author Reza-Zaldívar, Edwin E.
Jacobo-Velázquez, Daniel A.
author_facet Reza-Zaldívar, Edwin E.
Jacobo-Velázquez, Daniel A.
author_sort Reza-Zaldívar, Edwin E.
collection PubMed
description [Image: see text] Nowadays, nutraceuticals are being incorporated into functional foods or used as supplements with nonpharmacological approaches in the prevention and management of several illnesses, including age-related conditions and chronic neurodegenerative diseases. Nutraceuticals are apt for preventing and treating such disorders because of their nontoxic, non-habit-forming, and efficient bioactivities for promoting neurological well-being due to their ability to influence cellular processes such as neurogenesis, synaptogenesis, synaptic transmission, neuro-inflammation, oxidative stress, cell death modulation, and neuronal survival. The capacity of nutraceuticals to modify all of these processes reveals the potential to develop food-based strategies to aid brain development and enhance brain function, prevent and ameliorate neurodegeneration, and possibly reverse the cognitive impairment observed in Alzheimer’s disease, the most predominant form of dementia in the elderly. The current review summarizes the experimental evidence of the neuroprotective capacity of nutraceuticals against Alzheimer’s disease, describing their mechanisms of action and the in vitro and in vivo models applied to evaluate their neuroprotective potential.
format Online
Article
Text
id pubmed-10552500
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-105525002023-10-06 Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease Reza-Zaldívar, Edwin E. Jacobo-Velázquez, Daniel A. ACS Omega [Image: see text] Nowadays, nutraceuticals are being incorporated into functional foods or used as supplements with nonpharmacological approaches in the prevention and management of several illnesses, including age-related conditions and chronic neurodegenerative diseases. Nutraceuticals are apt for preventing and treating such disorders because of their nontoxic, non-habit-forming, and efficient bioactivities for promoting neurological well-being due to their ability to influence cellular processes such as neurogenesis, synaptogenesis, synaptic transmission, neuro-inflammation, oxidative stress, cell death modulation, and neuronal survival. The capacity of nutraceuticals to modify all of these processes reveals the potential to develop food-based strategies to aid brain development and enhance brain function, prevent and ameliorate neurodegeneration, and possibly reverse the cognitive impairment observed in Alzheimer’s disease, the most predominant form of dementia in the elderly. The current review summarizes the experimental evidence of the neuroprotective capacity of nutraceuticals against Alzheimer’s disease, describing their mechanisms of action and the in vitro and in vivo models applied to evaluate their neuroprotective potential. American Chemical Society 2023-09-20 /pmc/articles/PMC10552500/ /pubmed/37810693 http://dx.doi.org/10.1021/acsomega.3c04855 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Reza-Zaldívar, Edwin E.
Jacobo-Velázquez, Daniel A.
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
title Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
title_full Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
title_fullStr Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
title_full_unstemmed Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
title_short Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
title_sort comprehensive review of nutraceuticals against cognitive decline associated with alzheimer’s disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552500/
https://www.ncbi.nlm.nih.gov/pubmed/37810693
http://dx.doi.org/10.1021/acsomega.3c04855
work_keys_str_mv AT rezazaldivaredwine comprehensivereviewofnutraceuticalsagainstcognitivedeclineassociatedwithalzheimersdisease
AT jacobovelazquezdaniela comprehensivereviewofnutraceuticalsagainstcognitivedeclineassociatedwithalzheimersdisease